An allogeneic cell therapy company now offering contract manufacturing services is advising advanced therapy manufacturers to diversify and collaborate closely with suppliers, as well as understanding ...

Navigate the complexities of cell and gene therapy (CGT) supply chains with the 6 th Supply Chain & Logistics for Cell & Gene Therapies Summit. The official event guide is your practical roadmap to ...

The "Cell Therapy Processing: Global Markets and Technologies" report has been added to ResearchAndMarkets.com's offering. The global market for cell therapy processing is estimated to grow from $2.7 ...

The "Cell and Gene Therapy Supply Chain Software Market: Industry Trends and Global Forecasts to 2035: Distribution by Process Component, Type of Software, Mode of Deployment, Scale of Operation, Type ...

CAR-T therapies have proven their curative potential, but cell therapy developers continue to face challenges related to manufacturing complexities, costs, scalability, regulatory compliance, and ...

It could be years before a cell therapy from Nkarta reaches autoimmune disease patients in the market, but CEO Paul Hastings still thinks about the impact of pharmaceutical tariffs here and now. With ...